Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Presence of TERT ± BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma.

Surgery - 1 Sept 2021

Lee Jeonghun, Ha Eun Ju, Roh Jin, Kim Hyeung Kyoo

Abstract excerpt

BACKGROUND: The management of papillary thyroid microcarcinomas with TERT ± BRAF V600E mutations remains controversial owing to their potential associations with tumor aggressiveness. This study evaluated the clinical implications of these mutations in management of patients with papillary thyroid microcarcinomas. METHODS: Between June 2019 and October 2020, surgical specimens from 504 consecutive patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to Morbidity

Share to Republic of Korea

Share to Survival Rate

Share to Telomerase

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 33952391
DOI: 10.1016/j.surg.2021.03.056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Presence of TERT ± BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma.PMID 33952391Read ↗

Papillary microcarcinoma of the thyroid gland: Evaluation of TERT and BRAFV-600E expression and their relationship with clinicopathological findings.Semantic proximity Read ↗

A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.Semantic proximity Read ↗

Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.Semantic proximity Read ↗

TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.Semantic proximity Read ↗

Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.Semantic proximity Read ↗

Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in KoreansSemantic proximity Read ↗

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.Semantic proximity Read ↗

BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.Semantic proximity Read ↗

TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma.Semantic proximity Read ↗

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasisSemantic proximity Read ↗

BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.Semantic proximity Read ↗

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.